APA (7th ed.) Citation

Marmé, F., Werft, W., Benner, A., Burwinkel, B., Sinn, P., Sohn, C., . . . Schneeweiss, A. (2010). FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer. Annals of Oncology, 21(8), 1636. https://doi.org/10.1093/annonc/mdq017

Chicago Style (17th ed.) Citation

Marmé, F., W. Werft, A. Benner, B. Burwinkel, P. Sinn, C. Sohn, P. Lichter, M. Hahn, and A. Schneeweiss. "FGFR4 Arg388 Genotype Is Associated with Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer." Annals of Oncology 21, no. 8 (2010): 1636. https://doi.org/10.1093/annonc/mdq017.

MLA (9th ed.) Citation

Marmé, F., et al. "FGFR4 Arg388 Genotype Is Associated with Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer." Annals of Oncology, vol. 21, no. 8, 2010, p. 1636, https://doi.org/10.1093/annonc/mdq017.